Amgen Inc. (NASDAQ: AMGN)
Drug Manufacturers - General · Thousand Oaks, CA, United States · Founded 1980
- Market capitalization: $160.0 billion
- Annual revenue: $25.42 billion
- Net income: $7.71 billion
- Employees: 27,000
- Sector: Healthcare
- Headquarters: Thousand Oaks, United States
- Founded: 1980
Source: Statvoo company profile for Amgen Inc.. Browse all 500+ companies
Amgen is one of the world's largest biotechnology companies, specializing in treatments for cancer, cardiovascular disease, bone health, and inflammation. Key drugs include Enbrel (autoimmune), Prolia/Xgeva (bone), Repatha (cholesterol), and Lumakras (lung cancer). The company's obesity drug candidate (MariTide) has generated enormous investor excitement. Amgen was a pioneer of the biotech industry, founded in 1980 in Thousand Oaks, California.
Branded biologic and small-molecule drug sales drive virtually all revenue, which exceeds $28 billion annually. Amgen also has a growing biosimilars portfolio (copies of competitors' expired biologics). The $27.8 billion Horizon Therapeutics acquisition in 2023 added rare disease drugs. R&D spending exceeds $5 billion per year.
Founded in 1980 as Applied Molecular Genetics. Epogen (1989) for anemia in dialysis patients was the company's first blockbuster. Neupogen (1991) for chemotherapy patients followed. Amgen went public in 1983 at $18 per share. The Horizon Therapeutics acquisition in 2023 was the largest biotech deal in years. The company has been in Thousand Oaks, California since its founding.
| Market Capitalization | $160.0B |
| Annual Revenue | $25.42B |
| Net Income | $7.71B |
| Profit Margin | 30% |
| Revenue per Employee | $941481K |
| Stock Exchange | NASDAQ |
| Ticker Symbol | AMGN |
Financial data is approximate and based on most recent annual filings.
Amgen's campus in Thousand Oaks is so large it has its own zip code and fire department. Epogen was so profitable that it was nicknamed "Epo-gold." The company's early investors included venture capital legend Bill Bowes, who turned a $5 million investment into over $2 billion.
MariTide could be Amgen's ticket to the GLP-1 obesity gold rush u2014 if the data holds up, it would transform the company's growth trajectory; if not, the stock is priced for disappointment.
What is Amgen Inc.'s revenue?
Amgen Inc. generates approximately $25.42 billion in annual revenue.
How many employees does Amgen Inc. have?
Amgen Inc. employs approximately 27,000 people worldwide.
What is Amgen Inc.'s market cap?
Amgen Inc. (AMGN) has a market capitalization of approximately $160.0 billion on the NASDAQ.
When was Amgen Inc. founded?
Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, CA, United States.
Who is the CEO of Amgen Inc.?
Robert Bradway is the current CEO of Amgen Inc..
What is Amgen Inc.'s website?
Amgen Inc.'s official website is amgen.com.
| CEO | Robert Bradway |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Founded | 1980 |
| HQ | Thousand Oaks, CA |
| Country | United States |
| Website | amgen.com |
See traffic, security, and technical data for Amgen Inc.'s website:
📊 amgen.com stats 📋 WHOIS 🌐 DNS 🔒 SSL